ahlam1399
07-22-2015, 10:59 AM
Belgium?s Ablynx triples cooperation deal with Merck & Co
BRUSSELS, July 22 (Reuters) - Belgian biotech group Ablynx on Wednesday said it had tripled its research deal with U.S. drugmaker Merck & Co leading to potential milestone payments of about 4 billion euros ($4.38 billion).
http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2.img (http://da.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/ach.img (http://adchoice.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/ach.htm)http://pi.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4853aeba/sc/21/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=dJoSRl3c-LI:U2SlYdOtwF4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dJoSRl3c-LI:U2SlYdOtwF4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=dJoSRl3c-LI:U2SlYdOtwF4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dJoSRl3c-LI:U2SlYdOtwF4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=dJoSRl3c-LI:U2SlYdOtwF4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/dJoSRl3c-LI
BRUSSELS, July 22 (Reuters) - Belgian biotech group Ablynx on Wednesday said it had tripled its research deal with U.S. drugmaker Merck & Co leading to potential milestone payments of about 4 billion euros ($4.38 billion).
http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2.img (http://da.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/ach.img (http://adchoice.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/ach.htm)http://pi.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234565944728/u/49/f/654213/c/35217/s/4853aeba/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4853aeba/sc/21/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=dJoSRl3c-LI:U2SlYdOtwF4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dJoSRl3c-LI:U2SlYdOtwF4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=dJoSRl3c-LI:U2SlYdOtwF4:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dJoSRl3c-LI:U2SlYdOtwF4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=dJoSRl3c-LI:U2SlYdOtwF4:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/dJoSRl3c-LI